Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?

@article{Vaidyanathan2005RecurrentVC,
  title={Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?},
  author={Subramanian Vaidyanathan and Ian D Watson and Olof Jonsson and A Z Buczynski and Felix Grases and Ita Pfeferman Heilberg and Takahito Yasui and Jean-Jacques Wyndaele and Keiichi Tozawa and K. Kohri and Brigitte Schurch and P L Hughes and G Singh and B M Soni and P. K. Sett and William D. Fraser},
  journal={Spinal Cord},
  year={2005},
  volume={43},
  pages={269-277}
}
Study design:Clinical case report with comments by colleagues from Sweden, Poland, Spain, Brazil, Japan, Belgium and Switzerland.Objectives:To discuss the role of disodium etidronate therapy for prevention of calcium phosphate vesical calculi in persons with spinal cord injury, who have hypercalciuria and biochemical evidence of increased bone resorption.Setting:Regional Spinal Injuries Centre, Southport, UK.Methods:A 21-year-old male sustained paraplegia (T-10; ASIA scale: A) in a road traffic… 
Urolithiasis in patients with spinal cord injuries: risk factors, management, and outcomes
TLDR
The increased incidence of risks associated with urolithiasis lends support for routine genitourinary imaging in order to identify and treat those individuals at highest risk.
Bone disease in idiopathic hypercalciuria
TLDR
Whether hypercalciuria is the result of a primary bone disorder, a consequence of a persisting negative calcium balance or a combination of both still remains to be determined, Nevertheless, bone status must be evaluated and followed up in patients with idiopathic hyperCalciuria.
Re: effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
TLDR
Administration of aminobisphosphonates in association with thiazides produced the same clinical effects and also reduced calciuria and improved bone mineral density in patients with recurring renal calcium lithiasis.
Alendronate Reduces the Excretion of Risk Factors for Calcium Phosphate Stone Formation in Postmenopausal Women with Osteoporosis
TLDR
The results suggested that ALN not only improves BMD and osteoporosis, but also reduces the risk of calcium phosphate stone formation in postmenopausal women.
Treatment of immobilization hypercalciuria using weekly alendronate in two quadriplegic patients
TLDR
Two patients with high-level spinal cord injuries who have developed hypercalciuria after admission to the rehabilitation unit were treated successfully with alendronate, and twenty-four-hour urinary calcium excretion decreased significantly after medical treatment for hyperCalciuria.
Mechanisms of osteoporosis in spinal cord injury
TLDR
Because bone resorption after SCI is very high, intravenous bisphosphonates and denosumab should be considered for the treatment of osteoporosis afterSCI.
Clinical use of bisphosphonates in children
Conclusions: Intravenous bisphosphonates are well tolerated, even in infants and small children, and represent a promising therapeutic tool to prevent the development of bone fractures and to improve
Nephrologic issues in children with developmental disabilities.
  • T. Bunchman
  • Medicine
    Pediatric clinics of North America
  • 2008
TLDR
Both populations from a nephrologic viewpoint are explored, with a focus on children born with developmental disabilities and those born with chronic kidney disease.
Tratamiento de la litiasis renal con bifosfonatos
Resumen es: Objetivo: El tratamiento actual de la hipercalciuria aun es controvertido, no recomendandose la restriccion de calcio ya que puede producir un balance ne...
Interstitielle Zystitis: Interventionelle und operative Therapie – mehr als eine Ultima Ratio
Die interstitielle Zystitis ist eine häufig unterdiagnostizierte, chronisch-rezidivierend bis chronisch-progredient verlaufende Harnblasenerkrankung, deren Pathogenese und Ätiologie noch weitgehend
...
1
2
...

References

SHOWING 1-10 OF 21 REFERENCES
Effect of Etidronate Treatment on Bone Mass of Male Nephrolithiasis Patients with Idiopathic Hypercalciuria and Osteopenia
TLDR
The data suggest that etidronate given to young male CSF patients presenting with hypercalciuria and osteopenia led to a significant amelioration of BMD, evident only in the lumbar spine after 1 year of treatment.
Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards.
TLDR
Although disodium ethane-1-hydroxy-1,1-diphosphonate may be clinically useful to manage calcium urolithasis in certain patients its over-all use is limited because of its ineffectiveness in some patients and owing to its potential to induce osteomalacia.
Relationship of hypercalciuria to diet and bladder stone formation in spinal cord injury patients.
TLDR
Investigation of the effectiveness of a low calcium diet, low sodium diet, and hydrochlorthiazide to reduce urinary calcium excretion in spinal cord injured patients during the early phase of their rehabilitation found that recently injured patients developed hypercalciuria, however, there was no significant difference in the incidence of bladder stone formation.
Upper Urinary Tract Dilatation and Stones
There has been a profound change in the survival of patients with spinal injuries since the advent of specialised units dedicated to the care of these unfortunate patients. Soon after the first world
Interdependence of urinary factors in calcareous bladder stone patients
TLDR
“Path” analysis of the urinary parameters directly related to calcium lithiasis showed that magnesium and oxalic acid have substantial influence on calcium excretion, whereas citric acid had none.
Beneficial Effect of Intermittent Cyclical Etidronate Therapy in Hemiplegic Patients Following an Acute Stroke
  • Y. Sato, T. Asoh, M. Kaji, K. Oizumi
  • Medicine
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 2000
TLDR
It is suggested that etidronate can prevent decreases in the BMD in hemiplegic stroke patients because it decreases the serum calcium through inhibition of bone resorption and causes a subsequent increase in the serum 1,25(OH)2D concentration.
Bladder management and risk of bladder stone formation in spinal cord injured patients.
TLDR
In spinal cord injured patients long-term catheterization is associated with a substantial increased risk of bladder stone formation, independently of age, sex and injury level.
Inhibition of calcium oxalate urolithiasis in a rat model of lithogenesis using bisphosphonates.
TLDR
Older and newer-generation bisphosphonates have an inhibitory effect on calcium oxalate urolithiasis that is demonstrable at relatively infrequent dosing intervals in vivo, and more frequent dosing or higher doses may allow greater inhibition of stone formation.
Prevention of hypercalciuria and stone‐forming propensity during prolonged bedrest by alendronate
  • L. Ruml, S. Dubois, M. Roberts, C. Pak
  • Medicine
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 1995
TLDR
Alendronate inhibits bone mineral loss and averts the hypercalciuria and increased propensity for the crystallization of stone‐forming calcium salts which occurs during 3 weeks of strict bedrest.
Severe immobilization hypercalcemia, renal insufficiency, and calcification.
TLDR
This treatment regimen is suggested for use in patients with immobilization hypercalcemia when mobilization is impossible and the serum calcium concentration became normal rapidly rapidly.
...
1
2
3
...